SAN DIEGO, Calif.--(BUSINESS WIRE)--Element Biosciences today announced the close of a Series B financing round of $80.3 million, with participation from new investors Fidelity Management & Research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback